Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / COMMON STOCK-FO
-
Number of holders
-
476
-
Total 13F shares, excl. options
-
214,357,019
-
Shares change
-
+9,744,813
-
Total reported value, excl. options
-
$24,798,814,679
-
Value change
-
+$1,242,090,174
-
Put/Call ratio
-
322%
-
Number of buys
-
183
-
Number of sells
-
275
-
Price
-
$115.69
Institutional Holders of HORIZON THERAPEUTICS PLC - COMMON STOCK-FO (HZNP) as of Q3 2023
As of 30 Sep 2023 HORIZON THERAPEUTICS PLC - COMMON STOCK-FO (HZNP) had 476 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 214,357,019 shares of stock of the company.
Largest 10 holders included VANGUARD GROUP INC, Pentwater Capital Management LP, BlackRock Inc., HBK INVESTMENTS L P, UBS OCONNOR LLC, NORGES BANK, Avoro Capital Advisors LLC, FARALLON CAPITAL MANAGEMENT LLC, STATE STREET CORP, and JPMORGAN CHASE & CO.
This table shows 476 institutional shareholders of the security as of 30 Sep 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.